Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01456832 · ClinicalTrials.gov registry record
Post Operative Hyponatremia in the Renal Transplant Population
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 225
- Enrollment target
NCT01456832: Completed study, sponsored by Mayo Clinic.
NCT01456832 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 225 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01456832 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 225 participants
- Enrollment target
Study Summary
This study is designed to determine the causes of low sodium (salt) in the body fluids outside the cells for patients who have received a kidney transplant at the Mayo Clinic of Florida. The investigators will look at data collected on previous transplant patients at the Mayo Clinic to determine if the low sodium levels could be related to factors occurring in the course of surgery. The investigators hypothesize that the intravenous fluid used in the surgery, which is about half the concentration of normal saline, could contribute to the low sodium levels.
Primary Outcome
To study the incidence of post operative hyponatremia in patients undergoing renal transplant at our institution.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-10 |
What the finished NCT01456832 record still lists
NCT01456832 is an observational study that tracks outcomes without assigning an intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01456832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01456832 about?
NCT01456832 is a clinical study titled "Post Operative Hyponatremia in the Renal Transplant Population". This study is designed to determine the causes of low sodium (salt) in the body fluids outside the cells for patients who have received a kidney transplant at the Mayo Clinic of Florida. The investigators will look at data collected on previous transplant patients at the Mayo Clinic to determine if ...
What is the current status of trial NCT01456832?
This trial is currently completed. The enrollment target is 225 participants. The study started on 2010-01. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01456832?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia